150 related articles for article (PubMed ID: 12743598)
1. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity.
Adamson J; Morgan EA; Beesley C; Mei Y; Foster CS; Fujii H; Rudland PS; Smith PH; Ke Y
Oncogene; 2003 May; 22(18):2739-49. PubMed ID: 12743598
[TBL] [Abstract][Full Text] [Related]
2. Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells.
Jing C; Beesley C; Foster CS; Chen H; Rudland PS; West DC; Fujii H; Smith PH; Ke Y
Cancer Res; 2001 Jun; 61(11):4357-64. PubMed ID: 11389060
[TBL] [Abstract][Full Text] [Related]
3. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer.
Jing C; Beesley C; Foster CS; Rudland PS; Fujii H; Ono T; Chen H; Smith PH; Ke Y
Cancer Res; 2000 May; 60(9):2390-8. PubMed ID: 10811115
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
5. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis.
Huang S; Pettaway CA; Uehara H; Bucana CD; Fidler IJ
Oncogene; 2001 Jul; 20(31):4188-97. PubMed ID: 11464285
[TBL] [Abstract][Full Text] [Related]
6. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of stimulatory guanine nucleotide binding protein (G(S)alphaQL)-mediated signaling increases invasiveness and tumorigenicity of PC-3M prostate cancer cells.
Chien J; Wong E; Nikes E; Noble MJ; Pantazis CG; Shah GV
Oncogene; 1999 Jun; 18(22):3376-82. PubMed ID: 10362358
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
9. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression on human prostate cancer cells.
Miyagi T; Hori O; Koshida K; Egawa M; Kato H; Kitagawa Y; Ozawa K; Ogawa S; Namiki M
Int J Urol; 2002 Oct; 9(10):577-85. PubMed ID: 12445237
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of growth and metastasis of human giant cell carcinoma of the lung by transfection of antisense VEGF121 cDNA].
Wu X; Zheng J; Fu J; You J; Cui X; Wang J; Fang W; Zhou A; Wu B
Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):363-6. PubMed ID: 11866937
[TBL] [Abstract][Full Text] [Related]
12. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
13. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.
Jing C; El-Ghany MA; Beesley C; Foster CS; Rudland PS; Smith P; Ke Y
J Natl Cancer Inst; 2002 Apr; 94(7):482-90. PubMed ID: 11929948
[TBL] [Abstract][Full Text] [Related]
14. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
15. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.
Kelavkar UP; Nixon JB; Cohen C; Dillehay D; Eling TE; Badr KF
Carcinogenesis; 2001 Nov; 22(11):1765-73. PubMed ID: 11698337
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues.
Das R; Hammamieh R; Neill R; Melhem M; Jett M
Clin Cancer Res; 2001 Jun; 7(6):1706-15. PubMed ID: 11410510
[TBL] [Abstract][Full Text] [Related]
18. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein-IIA promoter induction alters rat intestinal fatty acid binding protein expression, fatty acid uptake, and lipid metabolism in transfected L-cells.
Prows DR; Schroeder F
Arch Biochem Biophys; 1997 Apr; 340(1):135-43. PubMed ID: 9126286
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
